However, dated and loose criteria for septic shock lead to the enrollment of highly heterogeneous patients, and anakinra did not reach statistical significance for reducing all-cause 28-day mortality in this setting.
← all excerpts
Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure.
1
—
—